Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IVVD | US
0
0%
Healthcare
Biotechnology
30/06/2024
16/04/2026
1.71
1.73
1.73
1.65
Invivyd Inc. a clinical-stage biopharmaceutical company focuses on the discovery development and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is adintrevimab a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease as well as developing monoclonal antibody candidates including VYD222 and VYD224 which provides neutralizing protection against SARS-CoV-2. It also has discovery stage candidates for the prevention of seasonal influenza. Invivyd Inc. has a collaboration agreement with Adimab LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention diagnosis or treatment of influenza or beta coronaviruses. The company was formerly known as Adagio Therapeutics Inc. and changed its name to Invivyd Inc. in September 2022. Invivyd Inc. was incorporated in 2020 and is headquartered in Waltham Massachusetts.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
171.4%1 month
144.7%3 months
102.7%6 months
116.7%-
-
0.82
0.00
0.00
0.78
3.04
-
-210.66M
204.25M
204.25M
-
-2.18K
-
-
-96.56
14.07
8.65
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.58
Range1M
0.63
Range3M
1.47
Rel. volume
0.32
Price X volume
2.15M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| LogicBio Therapeutics Inc | LOGC | Biotechnology | 8.5 | 223.33M | -3.41% | n/a | 0.00% |
| Lexeo Therapeutics Inc. Common Stock | LXEO | Biotechnology | 6.58 | 217.54M | -3.24% | n/a | 6.58% |
| Voyager Therapeutics Inc | VYGR | Biotechnology | 3.96 | 215.95M | -1.74% | 29.89 | 13.99% |
| MacroGenics Inc | MGNX | Biotechnology | 3.41 | 213.88M | -3.13% | n/a | 58.90% |
| Coherus BioSciences Inc | CHRS | Biotechnology | 1.9 | 210.29M | 1.06% | n/a | -354.71% |
| BioLineRx Ltd | BLRX | Biotechnology | 2.39 | 209.67M | 0.42% | n/a | 223.55% |
| Century Therapeutics Inc. Common Stock | IPSC | Biotechnology | 2.44 | 206.71M | -5.79% | n/a | 25.38% |
| MONOPAR THERAPEUTICS | MNPR | Biotechnology | 57.7 | 203.13M | -0.36% | n/a | 0.00% |
| C4 Therapeutics Inc | CCCC | Biotechnology | 2.9 | 201.08M | 0.35% | n/a | 27.69% |
| Ovid Therapeutics Inc | OVID | Biotechnology | 2.8 | 198.72M | 1.45% | n/a | 18.40% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CPI Card Group Inc | PMTS | Building Products & Equipment | 17.89 | 199.61M | 1.02% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 9.74 | 156.39M | 0.72% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.99 | 100.48M | 0.63% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.12 | 99.69M | 0.49% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.93 | 74.70M | 1.14% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.32 | 59.96M | 0.00% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 14 | 21.32M | 2.04% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.612 | 11.83M | -2.84% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.74 | 10.81M | 6.52% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.335 | 3.41M | -2.06% | n/a | 17.32% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.78 | - | Expensive |
| Ent. to Revenue | 3.04 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.82 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 102.71 | - | Riskier |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 204.25M | - | Emerging |